Multi-center clinical experience in 15 cases with the innovative CE-marked Cascade Net device was highlighted in the January 2020 Journal of Neurosurgery article, “Early experience with a novel net temporary bridging device (Cascade) to assist endovascular coil embolization of intracranial aneurysms” by Dr Alejandro Tomasello et al*.
Aliso Viejo, CA. – January 9, 2020 – MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.
This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients